• ...
  • ... (...)
  • Thermo Fisher Scientific Inc. (TMO)
  • NYSE
{"metrics":["Open"],"tickers":["TMO","JNJ","PFE","GILD","MRK","SPY"],"ticker_names":["Thermo Fisher Scientific Inc.","Johnson & Johnson","Pfizer Inc.","Gilead Sciences, Inc.","Merck & Co., Inc.","SPDR S&P 500 ETF Trust"]}
Previous Close: -
Volume: -
Market Cap: -
Enterprise Value: -
Last Quarterly Filing: -
Beta (5yr): -
Shares Outstanding: -
Revenue: -
Gross Margin: -
Net Margin: -
EPS: -
Price-to-Earnings: -
Price-to-Book: -

Relative Value Analysis

The graphs below are our team's statistical regressions on the key fundamental factors affecting valuations in this industry. Investments above the regression line indicate undervaluation versus peers.
{"metrics":[{"id":"xignite-real-time-fundamentals-five-year-annual-revenue-growth-rate","name":"Five Year Annual Revenue Growth Rate","parent_id":"xignite-real-time-fundamentals","entity_type":"real-time-fundamentals","data":{"Type":"FiveYearAnnualRevenueGrowthRate","Name":"Five Year Annual Revenue Growth Rate","ValueType":"Numeric","Unit":"Percent","Description":"The 5-Year Regression Growth Rate is the compound annual growth rate of the data item. This figure is derived by the least squares method, using six data points--a base year plus 5 subsequent annual data points. Fiscal year-end figures are used for the first 5 data points, with the calculation brought up to date each interim period by time-weighting the first and last points. An \"NC\" footnote appears for all companies that do not have a positive number for the 5-year period. A 5-year growth rate is not calculated for any company that has an incomplete record of data.","is_fund":false}},{"id":"xignite-real-time-fundamentals-free-cash-flow-per-share","name":"Free Cash Flow Per Share","parent_id":"xignite-real-time-fundamentals","entity_type":"real-time-fundamentals","data":{"Type":"FreeCashFlowPerShare","Name":"Free Cash Flow Per Share","ValueType":"Numeric","Unit":"$ & cents","Description":"[Cash from Operations minus Purchase of Plant, Property, and Equipment minus Payment of Cash Dividends] divided by the common shares outstanding (LTM).","is_fund":false}}],"equation":{"m":"","c":""},"variability":"","tickers":["JNJ","PFE","GILD","MRK","AMGN"]}
{"metrics":[{"id":"xignite-real-time-fundamentals-change-in-12-month-eps-vs.-1-year-ago","name":"Change in 12 Month EPS vs. 1 Year Ago","parent_id":"xignite-real-time-fundamentals","entity_type":"real-time-fundamentals","data":{"Type":"ChangeInTwelveMonthEPSVsOneYearAgo","Name":"Change in 12 Month EPS vs. 1 Year Ago","ValueType":"Numeric","Unit":"$ & cents","Description":"The dollar difference between the LTM EPS from total operations and the LTM EPS from total operations one year ago.","is_fund":false}},{"id":"xignite-real-time-fundamentals-current-12-month-normalized-p\/e-ratio","name":"Current 12 Month Normalized P\/E Ratio","parent_id":"xignite-real-time-fundamentals","entity_type":"real-time-fundamentals","data":{"Type":"CurrentTwelveMonthNormalizedPERatio","Name":"Current 12 Month Normalized P\/E Ratio","ValueType":"Numeric","Unit":"Ratio","Description":"P\/E calculated using LTM Diluted Normalized Net Income per Share which is calculated as follows: [Net Income from Continuing Operations minus Special Income\/Charges] divided by the diluted shares outstanding. Current (Latest) Ratios are calculated using the latest data available. CoreData pre-calculates the following ratios on a current basis. Income statement data will be LTM and Balance sheet data from the most recent quarter.","is_fund":false}}],"equation":{"m":"","c":""},"variability":"","tickers":["JNJ","PFE","GILD","MRK","AMGN"]}

Please select a profession that best describes you: